Abstract:China is home to a third of the world’s smokers and, correspondingly, to a third of the world’s cases of lung cancer. Beginning in the mid-1990s, a generation or so later than in many Western countries, the Chinese government commenced measures to control tobacco, limiting advertising, banning smoking in many public venues, and increasing taxation. At the time of this review, there are signs that these policies are having some effect, but hundreds of millions of Chinese continue to smoke and rates of diagnosis of lung cancer continue to rise. There is much work to be done and much premature death to be suffered before the epidemic is slowed to the levels reached in Australia or the United States. This article aims to provide, particularly for practicing lung cancer clinicians, a description of patterns of smoking in China, the lung cancer epidemic there, and the stimuli for and barriers to tobacco control imposed by the highly complex and unique regulatory setting of the Chinese tobacco industry. A particular challenge in developing this description has come from the variability of studies published about a huge nation that has enormous diversity in wealth, education, urbanization, and tradition. The studies vary because the data vary. Much information on lung cancer and smoking rates in China comes, for example, from studies of cohorts that may number in the millions yet represent only a small percentage of the population and sometimes only a tiny geographic area of such a vast nation. National registry data on lung cancer in China do not yet cover even a fifth of the national population. Even so, we argue that several major trends can be identified: (1) more than 50% of men smoke regularly; (2) there are more than 300 million smokers in China; (3) almost half a million new cases of lung cancer are diagnosed in China each year; (4) secondhand smoking is a significant problem in China (as elsewhere), accounting for a high proportion of lung cancer cases among women, most of whom do not smoke; (5) corrected for age and sex, lung cancer rates in the Chinese population are as least as high as in Western countries and arguably higher; and (6) a shift over time from squamous cell carcinoma (SCC) to adenocarcinoma is occurring in parallel with that noted in Western populations. Looking to the future, measures to control tobacco in China are strengthening but remain relatively weak. The reinforcement of control is hampered by the circumstance that the tobacco industry remains a powerful state-owned monopoly that participates, through its membership of key government bodies, in the processes that oversee the implementation of tobacco control. The conflict between the government’s dual responsibilities for both the production and distribution of tobacco and for the implementation of tobacco control carries inherent contradictions and bias. How long the Chinese government chooses to live with these contradictions will determine how quickly the smoking of tobacco will be reduced and how soon the burden of disease that tobacco inflicts on individuals and society as a whole will be eased.

On the Clinical Guideline for Smoking Cessation in China 2007

Behavioral Intervention Strategies to Nudge Smoking Cessation

Smoking cessation in an urban population in China.

Recent Advances in the Methods for Smoking Cessation

[Chronic cough in China: progress and perspectives].

Real-world Tobacco Cessation Practice in China: Findings from the Prospective, Nationwide Multicenter China National Tobacco Cessation Cohort Study (CNTCCS)

Systematic research on the prevalence of tobacco smoking, quite smoking and the practice of smoking cessation in Chinese doctors

Slowing the Titanic: China’s Epic Struggle with Tobacco

Guideline for [clinical Guidelines Constitution/Amendment] in China.

Evidence-Based Guideline for the Treatment of Smoking Cessation Provided by the National Health Insurance Service in Korea

Effects of Household, Workplace, and Public Place Smoking Restrictions on Smoking Cessation

[Present Status of Medical Treatment for Patients with Chronic Obstructive Pulmonary Disease Based Upon Different Severity Classifications].

Tobacco Advertising, Anti-Tobacco Information Exposure, Environmental Smoking Restrictions, and Unassisted Smoking Cessation among Chinese Male Smokers: A Population-Based Study

S2177 Inadequate Implementation of Guideline-Directed Smoking Cessation Treatment in Common Gastrointestinal Disorders: Insights From a Learning Health System

Development of clinical practice guidelines in 11 common diseases with Chinese medicine interventions in China

Quality Assessment of Clinical Guidelines in China: 1993 - 2010.

Analysis of the Status of Chinese clinical practice guidelines development

Clinical practice guideline in China: current status and thoughts

Nicotine Gum or Patch Treatment for Smoking Cessation and Smoking Reduction: a Multi-Centre Study in Chinese Physicians

The Quality of Clinical Practice Guidelines in China: a Systematic Assessment.

Quality assessment of clinical practice guidelines for respiratory diseases in China: A systematic appraisal